Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
Siltuximab (CNTO 328): a promising option for human malignancies
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
21,861 | Dovepress* | 18,451+ | 1,780 | 20,231 | |
PubMed Central* | 3,410 | 544 | 3,954 | ||
Totals | 21,861 | 2,324 | 24,185 | ||
*Since 2 July 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
3 | 0 | 0 | 0 | 1 | 2 |
View citations on PubMed Central and Google Scholar